Key Insights
The Infection Surveillance Solutions market, currently valued at $0.63 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 13.87% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of healthcare-associated infections (HAIs), coupled with stringent regulatory requirements for infection control and rising patient safety concerns, are significantly boosting demand for sophisticated surveillance solutions. Technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) in infection detection and prediction models, are enhancing the accuracy and efficiency of these systems. Furthermore, the growing adoption of cloud-based solutions offers scalability and cost-effectiveness, contributing to market growth. The market is segmented by offering (software and cloud services) and end-user (hospitals, long-term care facilities, and other end-users), with hospitals currently representing the largest segment due to their high infection risk environments and significant investment in advanced technologies. North America, particularly the United States, is expected to dominate the market initially, given the advanced healthcare infrastructure and higher adoption rates. However, Asia-Pacific is poised for significant growth due to increasing healthcare spending and rising awareness of infection control in developing economies. The market's restraints include high initial investment costs associated with implementing these systems, concerns regarding data privacy and security, and the need for skilled personnel to operate and maintain the technology.
The competitive landscape is characterized by a mix of established players like Becton Dickinson, Gojo Industries, and Epic Systems, and specialized solution providers such as RL Datix and VigiLanz. These companies are constantly innovating and expanding their product portfolios to cater to evolving market demands and technological advancements. Strategic partnerships and mergers and acquisitions are expected to play a crucial role in shaping the market's future. The forecast period (2025-2033) presents significant opportunities for market expansion, particularly with the focus shifting towards predictive analytics and proactive infection prevention strategies. The continuous evolution of technology and the increasing pressure to improve healthcare outcomes will propel the Infection Surveillance Solutions market to reach considerable heights in the coming years. Growth will likely be spurred by the increasing adoption of advanced technologies in developing nations and the rising demand for improved infection prevention and control methods globally.
Infection Surveillance Solutions Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Infection Surveillance Solutions market, projecting a robust growth trajectory fueled by technological advancements and increasing healthcare demands. Valued at xx Million in 2025, the market is poised for significant expansion, reaching xx Million by 2033, exhibiting a CAGR of xx% during the forecast period (2025-2033). This report covers the historical period (2019-2024), base year (2025), and estimated year (2025). Key players like Becton Dickinson and Company, Gojo Industries Inc., and Epic Systems Corporation are shaping this dynamic landscape. Download now to gain actionable insights and strategic advantages.

Infection Surveillance Solutions Industry Market Dynamics & Concentration
The Infection Surveillance Solutions market exhibits a moderately concentrated landscape, with several key players holding significant market share. Becton Dickinson and Company, Gojo Industries Inc., and Epic Systems Corporation are among the leading players, each contributing to a substantial portion of the overall market revenue (estimated at xx% combined market share in 2025). Market concentration is influenced by factors such as technological innovation, regulatory compliance, and strategic mergers and acquisitions (M&A).
- Innovation Drivers: The market is driven by continuous advancements in software, AI-powered analytics, and cloud-based services, leading to improved infection detection and prevention.
- Regulatory Frameworks: Stringent healthcare regulations and increasing emphasis on patient safety are shaping market dynamics and driving adoption of advanced solutions.
- Product Substitutes: While few direct substitutes exist, the market faces indirect competition from traditional infection control methods and alternative technologies.
- End-User Trends: Hospitals and long-term care facilities are the primary end-users, with a growing demand for integrated solutions to enhance infection surveillance and management.
- M&A Activities: The number of M&A deals in the infection surveillance solutions sector increased significantly during the last five years, with an estimated xx deals closing in 2024 alone. These acquisitions are facilitating market consolidation and technological integration.
Infection Surveillance Solutions Industry Industry Trends & Analysis
The Infection Surveillance Solutions market is witnessing robust growth, driven by several key factors. Rising healthcare expenditure, increasing prevalence of healthcare-associated infections (HAIs), and growing adoption of advanced technologies are contributing significantly to market expansion. The market’s growth is further accelerated by the increasing demand for real-time data analytics, predictive modeling, and improved infection prevention strategies. Technological advancements, particularly in AI and machine learning, are transforming the market by enhancing the accuracy and efficiency of infection surveillance systems. Consumer preferences are shifting towards user-friendly, integrated solutions that offer seamless data integration and actionable insights. The competitive dynamics are characterized by ongoing innovation, strategic partnerships, and market consolidation through acquisitions. The market is estimated to exhibit a CAGR of xx% during the forecast period, demonstrating strong growth momentum.

Leading Markets & Segments in Infection Surveillance Solutions Industry
North America currently dominates the global Infection Surveillance Solutions market, driven by high healthcare expenditure, advanced healthcare infrastructure, and strong regulatory support. Within this region, the US accounts for a lion's share of the market revenue.
By Offering:
- Software: This segment is the largest, driven by the demand for sophisticated analytics and data management capabilities.
- Cloud Services: The cloud-based segment is experiencing rapid growth due to its scalability, accessibility, and cost-effectiveness.
By End-User:
- Hospitals: Hospitals remain the largest end-user segment, owing to their significant infection control needs and investment in advanced technologies.
- Long-term Care Facilities: This segment is showing considerable growth due to increasing awareness of infection prevention in these settings and the introduction of specific solutions like Premier's PINC AI.
- Other End Users: This category encompasses various healthcare settings including clinics and ambulatory surgery centers. Market growth here is driven by the need for standardized infection prevention protocols across all settings.
Key Drivers:
- Strong healthcare infrastructure and robust IT capabilities.
- Favorable regulatory landscape and government initiatives.
- High healthcare expenditure.
Infection Surveillance Solutions Industry Product Developments
Recent product innovations focus on leveraging AI and machine learning to enhance infection detection, prediction, and prevention. New solutions offer integrated platforms that combine data from multiple sources for a holistic view of infection trends. Cloud-based solutions are becoming increasingly prevalent, providing accessibility, scalability, and reduced IT infrastructure costs. These advancements offer superior data analytics, predictive capabilities, and streamlined workflows leading to better infection control and improved patient outcomes.
Key Drivers of Infection Surveillance Solutions Industry Growth
The growth of the Infection Surveillance Solutions market is primarily driven by several factors:
- The rising incidence of healthcare-associated infections (HAIs) globally is a significant driver, pushing for improved surveillance and prevention methods.
- Technological advancements, such as AI and machine learning, are significantly enhancing the accuracy and efficiency of infection surveillance systems.
- Stringent regulatory frameworks and increasing government support for infection control programs are promoting the adoption of advanced solutions.
- Growing healthcare expenditure, especially in developed countries, fuels the investment in advanced infection surveillance technologies.
Challenges in the Infection Surveillance Solutions Industry Market
The Infection Surveillance Solutions market faces several challenges:
- High initial investment costs for advanced technologies can be a barrier to adoption, particularly for smaller healthcare facilities.
- Integration of data from various sources can be complex and time-consuming, requiring significant IT infrastructure and expertise.
- Maintaining data privacy and security is crucial; robust cybersecurity measures are essential to protect sensitive patient information. Breaches can lead to significant financial and reputational damage, estimated to cost an average of xx Million per incident.
Emerging Opportunities in Infection Surveillance Solutions Industry
The Infection Surveillance Solutions market offers significant growth opportunities, particularly through:
- The expansion of AI and machine learning capabilities to enhance predictive modeling and proactive infection prevention.
- Strategic partnerships between technology providers and healthcare organizations are fostering innovation and wider adoption.
- Expanding market penetration in emerging economies with rising healthcare expenditure and increasing awareness of infection control.
Leading Players in the Infection Surveillance Solutions Industry Sector
- Becton Dickinson and Company
- Gojo Industries Inc
- Epic Systems Corporation
- IBM Corporation (Truven Health Analytics)
- RL Datix Ltd
- Baxter International Inc (ICNet International)
- Cerner Corporation
- VigiLanz Corporation
- Theradoc (Premier Inc)
- DEB Group Ltd (SC Johnson & Son)
Key Milestones in Infection Surveillance Solutions Industry Industry
- June 2022: Premier introduced the PINC AI solution for long-term care facilities, significantly advancing technology in this sector.
- September 2022: GSK plc and Microsoft launched a disease surveillance project in Nepal using AI and robotics to combat vector-borne diseases, highlighting the potential of innovative partnerships.
Strategic Outlook for Infection Surveillance Solutions Industry Market
The Infection Surveillance Solutions market holds immense potential for growth. Continued technological innovation, particularly in AI and predictive analytics, will drive market expansion. Strategic partnerships and acquisitions will consolidate market share and foster innovation. Expanding into emerging markets and addressing unmet needs in underserved healthcare settings present significant opportunities. The focus on proactive infection prevention, rather than solely reactive measures, will further propel market growth in the coming years.
Infection Surveillance Solutions Industry Segmentation
-
1. Offering
-
1.1. Software
- 1.1.1. On-Premise
- 1.1.2. Cloud
-
1.2. Services
- 1.2.1. Maintenance and Support
- 1.2.2. Consultation and Training
- 1.2.3. Implementation Service
-
1.1. Software
-
2. End-User
- 2.1. Hospitals
- 2.2. Long-term Care Facilities
- 2.3. Other End Users
Infection Surveillance Solutions Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
-
2. Europe
- 2.1. United Kingdom
- 2.2. Germany
- 2.3. France
- 2.4. Italy
- 2.5. Spain
-
3. Asia
- 3.1. China
- 3.2. India
- 3.3. Japan
- 4. Australia and New Zealand
- 5. Latin America
- 6. Middle East and Africa

Infection Surveillance Solutions Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 13.87% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Stringent Government Policies for Preventing Hospital Associated Infections; Rise in the Number of Surgeries
- 3.3. Market Restrains
- 3.3.1. Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools
- 3.4. Market Trends
- 3.4.1. Infection Surveillance by Services is expected to Drive the Market Growth
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Offering
- 5.1.1. Software
- 5.1.1.1. On-Premise
- 5.1.1.2. Cloud
- 5.1.2. Services
- 5.1.2.1. Maintenance and Support
- 5.1.2.2. Consultation and Training
- 5.1.2.3. Implementation Service
- 5.1.1. Software
- 5.2. Market Analysis, Insights and Forecast - by End-User
- 5.2.1. Hospitals
- 5.2.2. Long-term Care Facilities
- 5.2.3. Other End Users
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia
- 5.3.4. Australia and New Zealand
- 5.3.5. Latin America
- 5.3.6. Middle East and Africa
- 5.1. Market Analysis, Insights and Forecast - by Offering
- 6. North America Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Offering
- 6.1.1. Software
- 6.1.1.1. On-Premise
- 6.1.1.2. Cloud
- 6.1.2. Services
- 6.1.2.1. Maintenance and Support
- 6.1.2.2. Consultation and Training
- 6.1.2.3. Implementation Service
- 6.1.1. Software
- 6.2. Market Analysis, Insights and Forecast - by End-User
- 6.2.1. Hospitals
- 6.2.2. Long-term Care Facilities
- 6.2.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Offering
- 7. Europe Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Offering
- 7.1.1. Software
- 7.1.1.1. On-Premise
- 7.1.1.2. Cloud
- 7.1.2. Services
- 7.1.2.1. Maintenance and Support
- 7.1.2.2. Consultation and Training
- 7.1.2.3. Implementation Service
- 7.1.1. Software
- 7.2. Market Analysis, Insights and Forecast - by End-User
- 7.2.1. Hospitals
- 7.2.2. Long-term Care Facilities
- 7.2.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Offering
- 8. Asia Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Offering
- 8.1.1. Software
- 8.1.1.1. On-Premise
- 8.1.1.2. Cloud
- 8.1.2. Services
- 8.1.2.1. Maintenance and Support
- 8.1.2.2. Consultation and Training
- 8.1.2.3. Implementation Service
- 8.1.1. Software
- 8.2. Market Analysis, Insights and Forecast - by End-User
- 8.2.1. Hospitals
- 8.2.2. Long-term Care Facilities
- 8.2.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Offering
- 9. Australia and New Zealand Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Offering
- 9.1.1. Software
- 9.1.1.1. On-Premise
- 9.1.1.2. Cloud
- 9.1.2. Services
- 9.1.2.1. Maintenance and Support
- 9.1.2.2. Consultation and Training
- 9.1.2.3. Implementation Service
- 9.1.1. Software
- 9.2. Market Analysis, Insights and Forecast - by End-User
- 9.2.1. Hospitals
- 9.2.2. Long-term Care Facilities
- 9.2.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Offering
- 10. Latin America Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Offering
- 10.1.1. Software
- 10.1.1.1. On-Premise
- 10.1.1.2. Cloud
- 10.1.2. Services
- 10.1.2.1. Maintenance and Support
- 10.1.2.2. Consultation and Training
- 10.1.2.3. Implementation Service
- 10.1.1. Software
- 10.2. Market Analysis, Insights and Forecast - by End-User
- 10.2.1. Hospitals
- 10.2.2. Long-term Care Facilities
- 10.2.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Offering
- 11. Middle East and Africa Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - by Offering
- 11.1.1. Software
- 11.1.1.1. On-Premise
- 11.1.1.2. Cloud
- 11.1.2. Services
- 11.1.2.1. Maintenance and Support
- 11.1.2.2. Consultation and Training
- 11.1.2.3. Implementation Service
- 11.1.1. Software
- 11.2. Market Analysis, Insights and Forecast - by End-User
- 11.2.1. Hospitals
- 11.2.2. Long-term Care Facilities
- 11.2.3. Other End Users
- 11.1. Market Analysis, Insights and Forecast - by Offering
- 12. North America Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 United States
- 12.1.2 Canada
- 12.1.3 Mexico
- 13. Europe Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 Germany
- 13.1.2 United Kingdom
- 13.1.3 France
- 13.1.4 Spain
- 13.1.5 Italy
- 13.1.6 Spain
- 13.1.7 Belgium
- 13.1.8 Netherland
- 13.1.9 Nordics
- 13.1.10 Rest of Europe
- 14. Asia Pacific Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 India
- 14.1.4 South Korea
- 14.1.5 Southeast Asia
- 14.1.6 Australia
- 14.1.7 Indonesia
- 14.1.8 Phillipes
- 14.1.9 Singapore
- 14.1.10 Thailandc
- 14.1.11 Rest of Asia Pacific
- 15. South America Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Peru
- 15.1.4 Chile
- 15.1.5 Colombia
- 15.1.6 Ecuador
- 15.1.7 Venezuela
- 15.1.8 Rest of South America
- 16. North America Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 16.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 16.1.1 United States
- 16.1.2 Canada
- 16.1.3 Mexico
- 17. MEA Infection Surveillance Solutions Industry Analysis, Insights and Forecast, 2019-2031
- 17.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 17.1.1 United Arab Emirates
- 17.1.2 Saudi Arabia
- 17.1.3 South Africa
- 17.1.4 Rest of Middle East and Africa
- 18. Competitive Analysis
- 18.1. Global Market Share Analysis 2024
- 18.2. Company Profiles
- 18.2.1 Becton Dickinson and Company
- 18.2.1.1. Overview
- 18.2.1.2. Products
- 18.2.1.3. SWOT Analysis
- 18.2.1.4. Recent Developments
- 18.2.1.5. Financials (Based on Availability)
- 18.2.2 Gojo Industries Inc
- 18.2.2.1. Overview
- 18.2.2.2. Products
- 18.2.2.3. SWOT Analysis
- 18.2.2.4. Recent Developments
- 18.2.2.5. Financials (Based on Availability)
- 18.2.3 Epic Systems Corporation
- 18.2.3.1. Overview
- 18.2.3.2. Products
- 18.2.3.3. SWOT Analysis
- 18.2.3.4. Recent Developments
- 18.2.3.5. Financials (Based on Availability)
- 18.2.4 IBM Corporation (Truven Health Analytics)
- 18.2.4.1. Overview
- 18.2.4.2. Products
- 18.2.4.3. SWOT Analysis
- 18.2.4.4. Recent Developments
- 18.2.4.5. Financials (Based on Availability)
- 18.2.5 RL Datix Ltd
- 18.2.5.1. Overview
- 18.2.5.2. Products
- 18.2.5.3. SWOT Analysis
- 18.2.5.4. Recent Developments
- 18.2.5.5. Financials (Based on Availability)
- 18.2.6 Baxter International Inc (ICNet International)
- 18.2.6.1. Overview
- 18.2.6.2. Products
- 18.2.6.3. SWOT Analysis
- 18.2.6.4. Recent Developments
- 18.2.6.5. Financials (Based on Availability)
- 18.2.7 Cerner Corporation
- 18.2.7.1. Overview
- 18.2.7.2. Products
- 18.2.7.3. SWOT Analysis
- 18.2.7.4. Recent Developments
- 18.2.7.5. Financials (Based on Availability)
- 18.2.8 VigiLanz Corporation
- 18.2.8.1. Overview
- 18.2.8.2. Products
- 18.2.8.3. SWOT Analysis
- 18.2.8.4. Recent Developments
- 18.2.8.5. Financials (Based on Availability)
- 18.2.9 Theradoc (Premier Inc)*List Not Exhaustive
- 18.2.9.1. Overview
- 18.2.9.2. Products
- 18.2.9.3. SWOT Analysis
- 18.2.9.4. Recent Developments
- 18.2.9.5. Financials (Based on Availability)
- 18.2.10 DEB Group Ltd (SC Johnson & Son)
- 18.2.10.1. Overview
- 18.2.10.2. Products
- 18.2.10.3. SWOT Analysis
- 18.2.10.4. Recent Developments
- 18.2.10.5. Financials (Based on Availability)
- 18.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global Infection Surveillance Solutions Industry Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: North America Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 3: North America Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 4: Europe Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 5: Europe Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 6: Asia Pacific Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 7: Asia Pacific Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 8: South America Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 9: South America Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 10: North America Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 11: North America Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 12: MEA Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 13: MEA Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 14: North America Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 15: North America Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 16: North America Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 17: North America Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 18: North America Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 19: North America Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 20: Europe Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 21: Europe Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 22: Europe Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 23: Europe Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 24: Europe Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 25: Europe Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 26: Asia Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 27: Asia Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 28: Asia Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 29: Asia Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 30: Asia Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 31: Asia Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 32: Australia and New Zealand Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 33: Australia and New Zealand Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 34: Australia and New Zealand Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 35: Australia and New Zealand Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 36: Australia and New Zealand Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 37: Australia and New Zealand Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 38: Latin America Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 39: Latin America Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 40: Latin America Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 41: Latin America Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 42: Latin America Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 43: Latin America Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
- Figure 44: Middle East and Africa Infection Surveillance Solutions Industry Revenue (Million), by Offering 2024 & 2032
- Figure 45: Middle East and Africa Infection Surveillance Solutions Industry Revenue Share (%), by Offering 2024 & 2032
- Figure 46: Middle East and Africa Infection Surveillance Solutions Industry Revenue (Million), by End-User 2024 & 2032
- Figure 47: Middle East and Africa Infection Surveillance Solutions Industry Revenue Share (%), by End-User 2024 & 2032
- Figure 48: Middle East and Africa Infection Surveillance Solutions Industry Revenue (Million), by Country 2024 & 2032
- Figure 49: Middle East and Africa Infection Surveillance Solutions Industry Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 3: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 4: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: United States Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Canada Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Mexico Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 10: Germany Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: United Kingdom Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: France Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Spain Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Italy Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Spain Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Belgium Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Netherland Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Nordics Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Rest of Europe Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 21: China Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Japan Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: India Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: South Korea Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Southeast Asia Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Australia Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Indonesia Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Phillipes Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Singapore Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Thailandc Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Rest of Asia Pacific Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 33: Brazil Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Argentina Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: Peru Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Chile Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: Colombia Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Ecuador Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Venezuela Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Rest of South America Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 41: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 42: United States Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: Canada Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Mexico Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 46: United Arab Emirates Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Saudi Arabia Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: South Africa Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Rest of Middle East and Africa Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 51: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 52: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 53: United States Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Canada Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 55: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 56: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 57: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 58: United Kingdom Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 59: Germany Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: France Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 61: Italy Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: Spain Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 63: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 64: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 65: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 66: China Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 67: India Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: Japan Infection Surveillance Solutions Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 69: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 70: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 71: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 73: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 74: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 75: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Offering 2019 & 2032
- Table 76: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by End-User 2019 & 2032
- Table 77: Global Infection Surveillance Solutions Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Infection Surveillance Solutions Industry?
The projected CAGR is approximately 13.87%.
2. Which companies are prominent players in the Infection Surveillance Solutions Industry?
Key companies in the market include Becton Dickinson and Company, Gojo Industries Inc, Epic Systems Corporation, IBM Corporation (Truven Health Analytics), RL Datix Ltd, Baxter International Inc (ICNet International), Cerner Corporation, VigiLanz Corporation, Theradoc (Premier Inc)*List Not Exhaustive, DEB Group Ltd (SC Johnson & Son).
3. What are the main segments of the Infection Surveillance Solutions Industry?
The market segments include Offering, End-User.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.63 Million as of 2022.
5. What are some drivers contributing to market growth?
Stringent Government Policies for Preventing Hospital Associated Infections; Rise in the Number of Surgeries.
6. What are the notable trends driving market growth?
Infection Surveillance by Services is expected to Drive the Market Growth.
7. Are there any restraints impacting market growth?
Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools.
8. Can you provide examples of recent developments in the market?
September 2022: GSK plc and Microsoft, in an innovative partnership with the Centre for Health and Disease Studies (CHDS) Nepal, initiated a groundbreaking disease surveillance project in Nepal. This pilot program harnesses the advanced capabilities of Microsoft's Premonition systems and combines them with GSK's extensive knowledge in health and disease management. The primary goal of this endeavor is to explore the potential of artificial intelligence and robotics in bolstering the local community's ability to combat vector-borne diseases and address the challenges posed by climate change.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Infection Surveillance Solutions Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Infection Surveillance Solutions Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Infection Surveillance Solutions Industry?
To stay informed about further developments, trends, and reports in the Infection Surveillance Solutions Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence